ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NPCE Neuropace Inc

13.39
-0.51 (-3.67%)
May 03 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 43,122
Bid Price 13.15
Ask Price 14.28
News -
Day High 14.19

Low
3.80

52 Week Range

High
18.15

Day Low 13.57
Share Name Share Symbol Market Stock Type
Neuropace Inc NPCE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.51 -3.67% 13.39 17:40:49
Open Price Low Price High Price Close Price Previous Close
14.19 13.57 14.19 13.64 13.90
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
870 43,122 US$ 13.82 US$ 596,107 - 3.80 - 18.15
Last Trade Type Quantity Price Currency
17:40:48 formt 100 US$ 13.39 USD

Neuropace Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
386.05M 28.34M - 65.42M -32.96M -1.16 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Neuropace News

Date Time Source News Article
3/05/202416:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
3/05/202415:11Edgar (US Regulatory)Form 8-K - Current report
2/28/202419:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202419:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/28/202419:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202415:43Edgar (US Regulatory)Form 8-K - Current report
2/06/202418:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/02/202408:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/01/202420:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/26/202417:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/08/202406:05Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NPCE Message Board. Create One! See More Posts on NPCE Message Board See More Message Board Posts

Historical NPCE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week13.0314.1912.68813.5998,8720.362.76%
1 Month12.8515.774712.68814.01124,8000.544.20%
3 Months16.8718.1512.1014.17111,282-3.48-20.63%
6 Months7.1418.156.510112.5697,4936.2587.54%
1 Year4.9118.153.8010.5071,9808.48172.71%
3 Years24.4826.281.2210.7167,232-11.09-45.30%
5 Years23.2527.381.2211.9672,925-9.86-42.41%

Neuropace Description

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.

Your Recent History

Delayed Upgrade Clock